Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-DLL3, SC0001 Vector   (CAT#: GTVCR-WQ2444MR)

This product GTVCR-WQ2444MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting DLL3. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Humanized
RefSeq NM_016941.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 10683
UniProt ID Q9NYJ7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-DLL3, SC0001 Vector (GTVCR-WQ2444MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1360MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF10B, HGS-ETR2 Vector Vector HGS-ETR2
GTVCR-WQ1752MR IVTScrip™ pT7-VEE-mRNA-Anti-SOST, LY2541546 Vector Vector LY2541546
GTVCR-WQ1808MR IVTScrip™ pT7-VEE-mRNA-Anti-G, M777-16-3 Vector Vector M777-16-3
GTVCR-WQ292MR IVTScrip™ pSP6-VEE-mRNA-Anti-Dabigatran, aDabi-Fab Vector Vector aDabi-Fab
GTVCR-WQ2341MR IVTScrip™ pSP6-VEE-mRNA-Anti-GP, REGN-3470-3471-3479 Vector Vector REGN-3470-3471-3479
GTVCR-WQ1667MR IVTScrip™ pT7-VEE-mRNA-Anti-hly, KBSA301 Vector Vector KBSA301
GTVCR-WQ1776MR IVTScrip™ pT7-VEE-mRNA-Anti-PDCD1, LY3300054 Vector Vector LY3300054
GTVCR-WQ2335MR IVTScrip™ pT7-VEE-mRNA-Anti-GP, REGN3470-3471-3479 Vector Vector REGN3470-3471-3479
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.